Brief: Ipa Acquires The Carterra Lsa Instrument To Enhance Antibody Discovery And Bolster Its Ai Developments
20/03/2024 11:04
March 20 (Reuters) - Immunoprecise Antibodies Ltd
IPA.O :
* IPA ACQUIRES THE CARTERRA LSA® INSTRUMENT TO ENHANCE
ANTIBODY
DISCOVERY AND BOLSTER ITS AI DEVELOPMENTS
Source text for Eikon: ID:nBw6pf6Dma
Further company coverage: IPA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mindwalk Holdings
See all newsBrief: Mindwalk Holdings Corp. Announces Leadership Update
MindWalk Holdings Corp reports results for the quarter ended July 31 - Earnings Summary
Canada's MindWalk Q1 net loss widens on higher sales, marketing expenses
MindWalk Holdings Corp expected to post a loss of 8 cents a share - Earnings Preview
Brief: MindWalk Showcases Reefiq™ For Ai Drug Discovery At AMD Advancing Ai